Elderly patients with psoriasis: long-term efficacy and safety of modern treatments.

Katerina BakirtziElena SotiriouIlias PapadimitriouNikolaos SiderisEfstratios VakirlisAimillios LallasFoteini VraniDemetrios Ioannides

Published in: The Journal of dermatological treatment (2020)

Biologicals and apremilast demonstrate adequate efficacy in elderly psoriatic patients. Incidence and severity of reported adverse events were similar to those reported among patients of younger age in relevant clinical studies.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
rheumatoid arthritis
peritoneal dialysis
middle aged
ankylosing spondylitis
systemic lupus erythematosus
atopic dermatitis